20 Participants NeededMy employer runs this trial
AG-181 for Phenylketonuria
AM
Overseen ByAgios Medical Affairs
Age: 18+
Sex: Any
Trial Phase: Phase 1
Sponsor: Agios Pharmaceuticals, Inc.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
What You Need to Know Before You Apply
What is the purpose of this trial?
The primary purpose of this study is to assess the safety and tolerability of AG-181 in subjects with Phenylketonuria (PKU).
Are You a Good Fit for This Trial?
Inclusion Criteria
I have PKU with a specific genetic mutation (R408W).
A dietitian has approved that I can follow a specific diet for the study.
Key
See 3 more
What Are the Treatments Tested in This Trial?
Interventions
- AG-181
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Group I: Cohort 2 (Optional Cohort): AG-181Experimental Treatment1 Intervention
Subjects will receive AG-181.
Group II: Cohort 1: AG-181Experimental Treatment1 Intervention
Subjects will receive AG-181 from Day 1 to Day 28.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Agios Pharmaceuticals, Inc.
Lead Sponsor
Trials
55
Recruited
4,200+
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.